secondary immunodeficiency

sec·on·dar·y im·mu·no·de·fi·cien·cy

immunodeficiency with no evident defect in the lymphoid tissues, but rather hypercatabolism or loss of immunoglobulins such as occurs in familial idiopathic hypercatabolic hypoproteinemia, protein-losing enteropathy, nephrotic syndrome, uremia, malnutrition, infection, diabetes, or malignancy.

secondary immunodeficiency

a loss of immunity caused by a disease process or toxic effect of medication rather than by a failure or defect in T or B lymphocytes.

sec·on·dary im·mu·no·de·fi·cien·cy

(sekŏn-dār-ē imyū-nō-dĕ-fishĕn-sē)
Form with no evident defect in the lymphoid tissues, but rather hypercatabolism or loss of immunoglobulins.
Synonym(s): secondary agammaglobulinemia, secondary hypogammaglobulinemia.
Mentioned in ?
References in periodicals archive ?
In people with primary or secondary immunodeficiency, certain components of the immune system are either absent or functioning inadequately, leaving them more susceptible to infection.
To offer the proper diagnosis and treatment of patients presenting with features of primary and secondary immunodeficiency, I would develop and introduce in Sudan a complement, flow cytometry, or molecular test for primary immune deficiency disease.
27, 2013 /PRNewswire/ -- CSL Behring announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Hizentra (Immune Globulin Subcutaneous[Human]) for the treatment of primary immunodeficiency (PID) and for the treatment of secondary immunodeficiency (SID).
Vivaglobin is approved in the European Union and Switzerland for treating PI as well as secondary immunodeficiency (SI) patients.

Full browser ?